Diabetes management with Biosimilar Insulin- Glargine

Speciality: Endocrinology

Description:

A warm welcome to all the medical practitioners in this interesting session of biosimilar insulin Glargine which is a product of Biocon.

Insulin is a hormone secreted from pancreas that helps blood sugar to enter the body's cells so it can be used for energy. Insulin also signals the liver to store blood sugar for later use. It is one of the important components that helps in controlling diabetes in patients.

The speakers Dr. Sunil Gupta, Dr. Anil Bhansali and panel has provided an elaborative knowledge on biosimilar insulin Glargine in the management of diabetes in patients. 

Biosimilar insulins are manufactured in living organisms (e.g., yeast and bacteria) to produce large quantities of the product, which limits the ability to manufacture exact replicas of original biological medications. Insulin glargine is a synthetic version of human insulin that is FDA approved to treat adults and children. It is long-acting with the ability to control sugar all day long.

Therefore, listen to the webinar, grab the knowledge that is shared and follow HiDoc for more such interesting webinar sessions.
 

See More Webinars @ Hidoc Webinars